CTSL and cancer: One notable example is gallinamide A, a modified tetrapeptide that acts as a potent and selective inhibitor of the cysteine protease cathepsin L. Cathepsin L is often overexpressed or secreted by cancer cells to degrade extracellular matrix components, facilitating tumor invasion and metastasis.